From what I hear on various sites, I must be one of the

New Post Public Reply Private Reply Replies (1) Message Board
petemantx
743
From what I hear on various sites, I must be one of the only believers in IPIX that has no remorse or worry when those I have told about it (and who are now in the red, some deep in the red) bitch about it. Why?

I told them right off the bat that biotech was the riskiest sector of investing possible. I stressed they only invest what they could afford to lose. I told them there was a major effort by unknown bodies to try and sabotage the future of IPIX, IMO these being BPs whose drugs are going to be made irrelevant by IPIXs.

On the other hand, I point to where IPIX is today, which IMO is right on the cusp of being wildly successful. IMO you have to risk big to win big. IPIX is one of the few that allows that dream to become a reality. I have staked a lot on this becoming true and hold little worry that it will fail.

I tell them don't bother me until we get word back on the upcoming human trial results for CV19. IMO that will be the first nut to crack with the OM and IBD trial successes following close behind. I tell them by the end of the year they could (not will, but could) see a return of their investment that will buckle their knees and by next Mar or so the return could make the end of the year price look like peanuts. A sure thing, no, but at this stage of the game a very, very, very good chance to happen.

So I end it with them at this juncture to just follow IPIX CLOSELY. When the news starts (and I believe the publicity starts in Sept) and things start percolating they should consider diving in and then it is their own responsibility to decide when to get out. As of now, anyone that invested within the last 18 months had the chance to earn a great return on their investment if they sold when prices were in the .50 range. Their greed kept them in, that is not my problem.

If some people lose a little money on IPIX, I will feel bad for them. If some never had the chance to make a fortune, I will feel terrible that I didn't allow them that opportunity by at least making it known to them.

I don't badger people to buy it, I just mention my investment if asked and say it is something they may want to follow. I do affirm I heartily recommend them to at least follow it.
1

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Davos Healthcare Aims to Revolutionize Hospital Ratings

Updated Category News Views 3

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Cracking the Code of America's Delivery Addiction

Updated Category News Views 4

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 8

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
AI-Driven Lumi Transforms Car Dealership Interactions

Updated Category News Views 7

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Continue Reading
Anecdotes by Artists Brings Raw Scent Stories to Sephora

Updated Category News Views 2

When Maesa pulls back the curtain, they don't just crack it open—they fling it aside with flair. That's precisely what they're doing with their latest venture, Anecdotes by Artists, a fragrance brand that's taking its first bow exclusively at Sephora. It's not your average perfume launch; it's about the stories behind the scents and the artists who craft them. Unveiling...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
FutureVault's AI Agents: Transforming Financial Workflows

Updated Category News Views 4

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Continue Reading
FJBio Boosts Antibody Discovery with Sapio AI

Updated Category News Views 2

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Continue Reading

Top 5 Most Recently Viewed Articles

Early Warrant Exercise Incentive Program: Key Highlights

Updated Category News Views 175

Inventus Mining Announces New Warrant Exercise Initiative Inventus Mining Corp. (TSXV: IVS) is thrilled to unveil its latest initiative, designed to inspire investors to partake in the early exercise of outstanding common share purchase warrants. This program marks a significant step forward for the company as it seeks to leverage its existing relationships with...

Continue Reading
Essential Insights for Investors of Alarum Technologies - ALAR

Updated Category News Views 155

Important Updates for Investors of Alarum Technologies Investors in Alarum Technologies Ltd (NASDAQ: ALAR) are faced with significant developments that could impact their stakes in the company. Recently, a national securities law firm began investigating potential claims against Alarum Technologies and Houston Holdings Ltd. Investors who have suffered notable losses are...

Continue Reading
CE-LINK's Innovative Solid-State Battery Power Bank Launch

Updated Category News Views 287

Revolutionizing Mobile Charging with Solid-State Battery Technology CE LINK LIMITED, a prominent manufacturer in consumer electronics, has introduced its latest power bank series featuring state-of-the-art solid-state battery technology. This breakthrough aims to redefine the standards of safety and performance in mobile charging. Visitors can experience this...

Continue Reading
Chipotle's Exciting Return of Special Chicken Al Pastor Menu

Updated Category News Views 103

Chipotle Announces the Return of Chicken al Pastor Chipotle Mexican Grill is revamping its menu by reintroducing Chicken al Pastor, a beloved protein known for its bold and vibrant flavors. This fan-favorite features a unique combination of adobo, morita peppers, and ground achiote, all complemented with fresh lime, cilantro, and a hint of pineapple. The Chicken al Pastor...

Continue Reading
AmpliTech Sees Impressive Cash Flow From Recent Product Sales

Updated Category News Views 76

AmpliTech Group Reports Cash Flow Exceeding $700,000 AmpliTech Group, Inc. (NASDAQ: AMPG, AMPGW), recognized as a frontrunner in advanced signal processing component design and manufacturing, has made an impressive announcement. Their Spectrum Semiconductor Materials Division has achieved a substantial cash influx of over $700,000 from a significant sale. This milestone...

Continue Reading